Summit Therapeutics' (SMMT) shares were up nearly 1% in Wednesday trading after Jefferies upgraded the company's stock to buy from hold and raised its price target to $25 from $15.
Trading volume stood at over 3.1 million shares compared with a daily average of roughly 5.3 million.
Price: $17.40, Change: $+0.12, Percent Change: +0.69%